SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001328143-21-000019
Filing Date
2021-02-23
Accepted
2021-02-23 16:01:07
Documents
91
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adms-20201231.htm   iXBRL 10-K 1974693
2 EX-2.1 adms10k2020ex21.htm EX-2.1 436418
3 EX-10.6 adms10k2020ex106.htm EX-10.6 228284
4 EX-10.19 adms10k2020ex1019.htm EX-10.19 87420
5 EX-10.22 adms10k2020ex1022.htm EX-10.22 5919
6 EX-10.31 adms10k2020ex1031.htm EX-10.31 64530
7 EX-21.1 adms10k2020ex211.htm EX-21.1 2956
8 EX-23.1 adms10k2020ex231.htm EX-23.1 2992
9 EX-31.1 adms10k2020ex311.htm EX-31.1 11307
10 EX-31.2 adms10k2020ex312.htm EX-31.2 11282
11 EX-32.1 adms10k2020ex321.htm EX-32.1 7943
  Complete submission text file 0001328143-21-000019.txt   9984172

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20201231.xsd EX-101.SCH 54388
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20201231_cal.xml EX-101.CAL 104687
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20201231_def.xml EX-101.DEF 347826
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20201231_lab.xml EX-101.LAB 789950
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20201231_pre.xml EX-101.PRE 524027
17 EXTRACTED XBRL INSTANCE DOCUMENT adms-20201231_htm.xml XML 1421356
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36399 | Film No.: 21665304
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences